Otonomy Inc OTIC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:25 PM EDT
0.37quote price arrow down-0.01 (-1.62%)
Volume
20,111
Close
0.371quote price arrow up+0.001 (+0.27%)
Volume
1,085,612
52 week range
0.24 - 2.59
Loading...
  • Open0.36
  • Day High0.378
  • Day Low0.3561
  • Prev Close0.37
  • 52 Week High2.59
  • 52 Week High Date03/22/22
  • 52 Week Low0.24
  • 52 Week Low Date08/02/22

Key Stats

  • Market Cap21.14M
  • Shares Out56.99M
  • 10 Day Average Volume8.55M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • YTD % Change-82.16

KEY STATS

  • Open0.36
  • Day High0.378
  • Day Low0.3561
  • Prev Close0.37
  • 52 Week High2.59
  • 52 Week High Date03/22/22
  • 52 Week Low0.24
  • 52 Week Low Date08/02/22
  • Market Cap21.14M
  • Shares Out56.99M
  • 10 Day Average Volume8.55M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • YTD % Change-82.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.78
  • P/E (TTM)-0.47
  • Fwd P/E (NTM)-0.59
  • EBITDA (TTM)-50.768M
  • ROE (TTM)-96.77%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-300.00%
  • Net Margin (TTM)-150,065.70%
  • Debt To Equity (MRQ)50.97%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Otonomy Inc

There is no recent news for this security.

Profile

MORE
Otonomy, Inc. is a biopharmaceutical company. The Company is focused on the development of therapeutics for neurotology. The Company pipeline includes OTIPRIO, OTIVIDEX, OTO-313, and OTO-413. OTIPRIO is a single-dose, physician-administered antibacterial for the treatment of pediatric patients with bilateral otitis media with effusion undergoing TTP surgery for the treatment of patients with acute otitis externa (AOE). OTIVIDEX is a sustained-exposure formulation of the...
Jay Lichter Ph.D.
Independent Chairman of the Board
David Weber Ph.D.
President, Chief Executive Officer, Director
Paul Cayer
Chief Financial, Business Officer
Robert Savel II
Chief Technical Officer
Address
5626 OBERLIN DRIVE, SUITE 100
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
GRAY
Graybug Vision Inc
0.9998-0.0102-1.0099%
MTCR
Metacrine Inc
0.499-0.001-0.20%
PBLA
Panbela Therapeutics Inc
1.37+0.06+4.58%
IDRA
Idera Pharmaceuticals Inc
0.4793+0.0062+1.31%
SLNO
Soleno Therapeutics Inc
0.195+0.017+9.55%